Beezaasan Exp. (544369)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 21.11% indicates efficient capital deployment
• Piotroski F-Score 7/9 suggests sound financial health
• Latest quarter net profit of ₹8 Cr on sales of ₹100 Cr implies an 8% net margin
• Positive sales and profit growth, though modest, show the business is not shrinking

Concerns

• P/E of 23.95 is expensive relative to profit growth of 2.47%
• PEG ratio of 8.24 implies significant overvaluation for the current growth rate
• No dividend yield, so shareholders earn no income while waiting
• Lack of ROE, book value, and promoter holding data limits full fundamental assessment

AI Analysis

At first glance, Beezaasan Exp. illustrates why price and value are different things. Yes, the company operates in explosives, a niche industry. But my tests are about returns on capital, growth, and the price I pay. ROCE is 21.11%, which is respectable—it suggests management can deploy capital without destroying value. The Piotroski F-Score of 7 out of 9 also tells me the balance sheet and operations look reasonably sound today. But I am not buying a balance sheet; I am buying future earnings. Sales grew only 3.34% and profit grew 2.47%. That is close to inflation, not compounding. At ₹231.50, market cap is ₹299 Cr and P/E is 23.95. For a business growing earnings at 2.47%, paying 24 times earnings is steep. The PEG of 8.24 is far above any comfortable level; it implies either growth must improve dramatically or the price must fall. In the latest quarter, sales were ₹100 Cr and net profit ₹8 Cr—an 8% margin, decent but not special. There is no dividend, so the shareholder receives no cash while waiting. I miss ROE, book value, and promoter holding data; without them, I cannot judge insider alignment or true equity quality. This looks like a slow grower, not a compounding machine. Benjamin Graham would ask for a margin of safety. At 24 times earnings with low growth, I do not see one. I would put this on the watchlist, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer